A new research report from Statler Nagle, LLC concludes that the shift to recombinant bovine somatotropin (rbST)-free milk was an overly quick response to a problem that seemed bigger than it was in reality. Study findings suggest that although only 8 to 12% of consumers were concerned enough about rbST to change purchasing or consumption behaviors, milk-processing companies instead opted … Read More
Monsanto Looks to Sell Posilac
Monsanto announced today that it is pursuing a divestiture of its dairy product, POSILAC® bovine somatotropin (commonly known as rBST). Additional details have not been disclosed at this time. “While POSILAC is a strong product for the business, we believe repositioning the business with a strategic owner will allow Monsanto to focus on the growth of its core seeds and … Read More